Insulet (PODD) Cash & Current Investments (2010 - 2026)

Insulet (PODD) reported Cash & Current Investments of $480.4 million for Q1 2026, down 62.56% on a YoY basis from $1.3 billion in Q1 2025, and down 32.91% quarter-over-quarter from $716.1 million in Q4 2025.

Insulet (PODD) Cash & Current Investments (2010 - 2026) Analysis & Trends

Insulet has reported Cash & Current Investments for 17 years, with the latest figure at $480.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Current Investments fell 62.56% year-over-year to $480.4 million; the trailing twelve-month figure through Mar 2026 stood at $480.4 million (down 62.56% YoY), and the FY2025 full-year result was $716.1 million, down 24.89% from the prior year.
  • Cash & Current Investments for Q1 2026 stood at $480.4 million, down from $716.1 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $1.3 billion in Q1 2025, with the low at $480.4 million in Q1 2026.
  • Historically, Cash & Current Investments has averaged $782.7 million across 5 years, with a median of $716.1 million in 2025.
  • Annual changes were most pronounced in 2025 — Cash & Current Investments surged 70.81% — and 2026, when it sank 62.56%.
  • Insulet's Cash & Current Investments stood at $675.2 million in 2022, then rose by 4.3% to $704.2 million in 2023, then jumped by 35.39% to $953.4 million in 2024, then slipped by 24.89% to $716.1 million in 2025, then tumbled by 32.91% to $480.4 million in 2026.
  • The last three Cash & Current Investments figures came in at $480.4 million (Q1 2026), $716.1 million (Q4 2025), and $757.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 7.30 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 2.88 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 8.38 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.45 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 3.67 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 3.12 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 1.12 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 2.29 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 439.60 Mn
10 Insulet 10.20 Bn 9.72 Bn 529.10 Mn 480.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 480.40 Mn
Dec 31, 2025 716.10 Mn
Sep 30, 2025 757.40 Mn
Jun 30, 2025 1.12 Bn
Mar 31, 2025 1.28 Bn
Dec 31, 2024 953.40 Mn
Sep 30, 2024 902.60 Mn
Jun 30, 2024 821.00 Mn
Mar 31, 2024 751.20 Mn
Dec 31, 2023 704.20 Mn
Sep 30, 2023 701.00 Mn
Jun 30, 2023 675.50 Mn
Mar 31, 2023 620.70 Mn
Dec 31, 2022 675.20 Mn
Sep 30, 2022 722.50 Mn
Jun 30, 2022 709.80 Mn
Mar 31, 2022 710.70 Mn
Dec 31, 2021 793.20 Mn
Sep 30, 2021 857.10 Mn
Jun 30, 2021 872.10 Mn